Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Infusion Set Replacement Intervals on Central Line-associated Bloodstream Infection in Adult Intensive Care Unit: a Multicenter Randomised Clinical Trial

NCT05359601 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT05359601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05359601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Infusion Set Replacement Intervals on Central Line-associated Bloodstream Infection in Adult Intensive Care Unit: a Multicenter Randomised Clinical Trial
Lead sponsor
Zhongnan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 15, 2022
Completion date
June 30, 2026
Enrollment
1,240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness